Eris Lifesciences: Independent Director Rajeev Dalal's Term Ends Dec 18

Eris Lifesciences Limited has announced that the term of Mr. Rajeev Dalal as a Non-Executive, Independent Director of the Company will conclude on December 18, 2025. His appointment, approved by the m...

Eris Lifesciences Limited has announced that the term of Mr. Rajeev Dalal as a Non-Executive, Independent Director of the Company will conclude on December 18, 2025. His appointment, approved by the members at the Fifteenth Annual General Meeting held on September 01, 2021, was for a five-year term commencing December 19, 2020. Consequently, Mr. Dalal will cease to be an Independent Director and his membership and chairmanship in various Board committees will also end on the same date. The Board and Management of Eris Lifesciences expressed their sincere appreciation for Mr. Dalal's valuable contributions during his tenure. The disclosure is made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Limitations of AI summaries

AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.

Platforms like Prysm provide stock-level and portfolio-level analysis.

Why is Eris Lifesciences Limited in the news today?

Eris Lifesciences Limited (ERIS) is in the news due to the announcement is a routine disclosure regarding the completion of an independent director's tenure and does not contain information that significantly impacts the company's financial performance or future outlook.

Board ChangesOther Regulatory Filings
Eris Lifesciences LimitedERIShttps://prysm.fi/v2/analyze/ERIS

AI-Powered Summary

Market Context

Top Queries

More News

Explore Prysm Tools

Related Stories

Eris Lifesciences: Independent Director Rajeev Dalal's Term Ends Dec 18

December 18, 2025, 10:21 AM

AI Sentiment Analysis

Eris Lifesciences Limited has announced that the term of Mr. Rajeev Dalal as a Non-Executive, Independent Director of the Company will conclude on December 18, 2025. His appointment, approved by the members at the Fifteenth Annual General Meeting held on September 01, 2021, was for a five-year term commencing December 19, 2020.

Consequently, Mr. Dalal will cease to be an Independent Director and his membership and chairmanship in various Board committees will also end on the same date. The Board and Management of Eris Lifesciences expressed their sincere appreciation for Mr. Dalal's valuable contributions during his tenure.

The disclosure is made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

See What Deep Dive Gives You — in Seconds

“what happens when you click Deep Dive “

Instant AI Summary - “Get clean, noise-free earnings breakdowns.”

PDF Insights - “Download detailed, AI-generated reports.”

Metrics Explained - “Key ratios & trends explained in simple language.”

Want to know if this news pushes your stock up or down?

Just tap

deep dive

Top Queries to Ask About Eris Lifesciences Limited

More News on Eris Lifesciences Limited

Discover more trending news on Prysm

View All